Literature DB >> 11551630

The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes.

C S Gavigan1, J P Dalton, A Bell.   

Abstract

Intra-erythrocytic Plasmodium parasites digest host cell haemoglobin and use the liberated amino acids for protein synthesis. Although several endoproteases (aspartic, cysteine, and metallo-) have been shown to be involved in the initial stages of haemoglobin degradation, little is known about the steps immediately before amino acid release. In our studies, fluorometric enzyme assays indicated that the stage of the P. falciparum erythrocytic cycle with highest aminopeptidase activity was the stage at which most haemoglobin degradation occurs, i.e. the trophozoite. Consistent with these results, metabolic growth assays indicated that the late ring/trophozoite stage was most susceptible to aminopeptidase inhibitors. To reconstitute the terminal stages of haemoglobin breakdown in vitro, we synthesised three peptides with amino acid sequences corresponding to known products of the endoproteolytic digestion of haemoglobin and employed them as substrates for aminopeptidases. Both trophozoite cytosolic extract, and partially-purified aminopeptidase, hydrolysed these peptide fragments to amino acids. Hydrolysis appeared to occur sequentially from the amino-termini of the peptides, and was inhibited in a concentration-dependent manner by the aminopeptidase-specific inhibitor nitrobestatin. The results suggest that P. falciparum aminopeptidases could be the enzymes responsible for the hydrolysis of haemoglobin-derived peptides to free amino acids. Lack of ultrastructural change in parasites treated with relevant concentrations of aminopeptidase-specific inhibitors, however, indicated that little feedback exists whereby the inhibition of cytosolic aminopeptidases results in obvious inhibition of initial haemoglobin degradation in the digestive vacuole.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551630     DOI: 10.1016/s0166-6851(01)00327-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  18 in total

1.  Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase.

Authors:  Sheena McGowan; Corrine J Porter; Jonathan Lowther; Colin M Stack; Sarah J Golding; Tina S Skinner-Adams; Katharine R Trenholme; Franka Teuscher; Sheila M Donnelly; Jolanta Grembecka; Artur Mucha; Pawel Kafarski; Ross Degori; Ashley M Buckle; Donald L Gardiner; James C Whisstock; John P Dalton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

Review 2.  Proteases as regulators of pathogenesis: examples from the Apicomplexa.

Authors:  Hao Li; Matthew A Child; Matthew Bogyo
Journal:  Biochim Biophys Acta       Date:  2011-06-13

3.  The thermophilic, homohexameric aminopeptidase of Borrelia burgdorferi is a member of the M29 family of metallopeptidases.

Authors:  Patrícia B Bertin; Silene P Lozzi; Jerrilyn K Howell; Glória Restrepo-Cadavid; David Neves; Antonio R L Teixeira; Marcelo V de Sousa; Steven J Norris; Jaime M Santana
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.

Authors:  Michael B Harbut; Geetha Velmourougane; Seema Dalal; Gilana Reiss; James C Whisstock; Ozlem Onder; Dustin Brisson; Sheena McGowan; Michael Klemba; Doron C Greenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.

Authors:  C S Gavigan; S G Machado; J P Dalton; A Bell
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

6.  Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.

Authors:  Eithne Cunningham; Marcin Drag; Pawel Kafarski; Angus Bell
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

7.  Aspartic proteases of Plasmodium vivax are highly conserved in wild isolates.

Authors:  Byoung-Kuk Na; Eung-Goo Lee; Hyeong-Woo Lee; Shin-Hyeong Cho; Young-An Bae; Yoon Kong; Jong-Koo Lee; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2004-06       Impact factor: 1.341

8.  Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum.

Authors:  Marcin Poreba; Sheena McGowan; Tina S Skinner-Adams; Katharine R Trenholme; Donald L Gardiner; James C Whisstock; Joyce To; Guy S Salvesen; John P Dalton; Marcin Drag
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  Trafficked Proteins-Druggable in Plasmodium falciparum?

Authors:  Jasmin Lindner; Kamila Anna Meissner; Isolmar Schettert; Carsten Wrenger
Journal:  Int J Cell Biol       Date:  2013-04-28

10.  Exploration of Sitagliptin as a potential inhibitor for the M1 Alanine aminopeptidase enzyme in Plasmodium falciparum using computational docking.

Authors:  Mohana Krishnamoorthy; Anant Achary
Journal:  Bioinformation       Date:  2013-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.